Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is a common and chronic gastrointestinal disorder. Probiotics may have the potential to impact the management of IBS; however, the results of trials are conflicting. This study aimed to investigate whether a mixture of lactobacilli probiotics could improve abdominal symptoms in patients with unconstipated IBS. Fifty Vietnamese patients with unconstipated IBS were randomly assigned to either the probiotics or placebo groups. During the intervention, participants took the probiotic supplement, named Foodis Lactobacillus, or placebo capsule once a day. Patients recorded their subject global assessment (SGA) weekly and were assessed with the visual analogue scale (VAS) during the 4-week study period. Patients with SGA score of 2 points or more or a decrease of more than 30% in VAS score were considered responders. Patients who responded weekly for more than 2 of the 4 weeks were considered overall responders. There was no significant difference in demographic characteristics between the groups. Overall responder rates of improvement of global IBS symptoms assessed by SGA score were significantly higher in the probiotics group (80.8%) than in the placebo group (45.8%) (p = 0.009). The overall responder rates assessed by VAS score were also higher in the probiotics group (69.2%, 41.7%, p = 0.048). There were no adverse events in either group during the study period. Our findings suggest that the new combination of Lactobacilli appears to be promising in the relief of abdominal symptoms in Vietnamese patients with unconstipated IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 2×
“They also produce some substances that have an antibiotic effect by fermenting undigested carbohydrates and dietary fiber, producing organic acids [39].”
BackgroundPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · cited 1×
“The prevalence of IBS ranges from <5% up to 20% depending on the criteria used [1].”
BackgroundO’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“This phenomenon may be due to cultural factors, degree of pain, socioeconomic conditions, and healthcare systems [19,20].”
BackgroundRifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036 · cited 1×
“Treating IBS is important because the symptoms cause impairment in health-related quality of life, leading to increased use of health resources and reduced work productivity [2].”
BackgroundProbiotics: effects on immunity
Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H., & Salminen, S. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.444s · Cited by 1,019 · cited 1×
“They increase the efficiency of the immunologic system, particularly intestinal IgA responses, and alleviation of intestinal inflammatory response [40].”
BackgroundFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747 · cited 1×
“Several meta-analyses of randomized controlled trials found probiotics to be more superior to placebo in reducing overall IBS symptoms and abdominal pain [10,11].”
BackgroundThe efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728
Mechanisms of probiotic actions – A review
Oelschlaeger, T. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.005 · Cited by 719 · cited 1×
“Their main beneficial effect is acting as a barrier to enteropathogens by adherence and competition with pathogens [37,38].”
BackgroundIntragastric nitric oxide production in humans: measurements in expelled air.
Lundberg, J. O., Weitzberg, E., Lundberg, J. M., & Alving, K. (1994) · Gut · doi:10.1136/gut.35.11.1543 · Cited by 661 · cited 1×
“plantarum to catabolize arginine and generate nitric oxide may exert a positive effect on the motility of intestine [45].”
BackgroundNobaek, S., Johansson, M.-L., Molin, G., Ahrné, S., & Jeppsson, B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02015.x · Cited by 653 · cited 1×
“plantarum group compared with the placebo [25].”
Ford, A. C., Harris, L. A., Lacy, B. E., Quigley, E. M. M., & Moayyedi, P. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15001 · Cited by 619
Kim, H. J., Camilleri, M., Mckinzie, S., Lempke, M. B., Burton, D. D., Thomforde, G. M., & Zinsmeister, A. R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01543.x · Cited by 468 · cited 1×
“A number of studies have been conducted on the effect of probiotics on IBS patients, and some of them have reported favorable outcomes [12,30,31].”
BackgroundMcCarthy, J., O’Mahony, L., O’Callaghan, L., Sheil, B., Vaughan, E. E., Fitzsimons, N., Fitzgibbon, J., O’Sullivan, G. C., Kiely, B., Collins, J. K., et al. (2003) · Gut · doi:10.1136/gut.52.7.975 · Cited by 462 · cited 1×
“salivarius may influence immune regulation by increased induction of interleukin-10 (IL-10) [43], an anti-inflammatory cytokine, and reduced secretion of proinflammatory cytokines, such as tumor necrosis factor (TNF) alpha, IL-12, and interferon (IFN) gamma [44].”
BackgroundReliability and validity of a visual analog scale for acute abdominal pain in the ED
Gallagher, E. J., Bijur, P. E., Latimer, C., & Silver, W. (2002) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2002.33778 · Cited by 457 · cited 2×
“They filled out the weekly questionnaires, which included a 5-point Likert scale of SGA [28] and VAS score [29].”
MethodSpecific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Kim, H. J., Vazquez Roque, M. I., Camilleri, M., Stephens, D., Burton, D. D., Baxter, K., Thomforde, G., & Zinsmeister, A. R. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00695.x · Cited by 400
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365 · cited 1×
“On the other hand, several studies failed to show improvement compared to placebo [32,33].”
BackgroundKAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361 · cited 1×
“A number of studies have been conducted on the effect of probiotics on IBS patients, and some of them have reported favorable outcomes [12,30,31].”
BackgroundIntestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?
Rajilić-Stojanović, M., Jonkers, D. M., Salonen, A., Hanevik, K., Raes, J., Jalanka, J., de Vos, W. M., Manichanh, C., Golic, N., Enck, P., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.427 · Cited by 359 · cited 1×
“Specific probiotic bacteria, Lactobacillus species, have been reported to be decreased in stool of IBS patients [41] and emerging evidences suggest that replacement of Lactobacilli appears to have beneficial effects on IBS.”
BackgroundDidari, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3072 · Cited by 356 · cited 1×
“Several meta-analyses of randomized controlled trials found probiotics to be more superior to placebo in reducing overall IBS symptoms and abdominal pain [10,11].”
BackgroundChong, P. P., Chin, V. K., Looi, C. Y., Wong, W. F., Madhavan, P., & Yong, V. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01136 · Cited by 328 · cited 1×
“However, much remains to be answered, as which strains and doses are most effective and which regimens of combination work best are still relatively unknown [16].”
BackgroundGut microbiota diversity across ethnicities in the United States
Brooks, A. W., Priya, S., Blekhman, R., & Bordenstein, S. R. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006842 · Cited by 304 · cited 1×
“In addition, gut microbiota differences between ethnicities have been studied and there is the potential to advance approaches aimed at personalized microbial treatment [14,15].”
BackgroundA systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome
Hoveyda, N., Heneghan, C., Mahtani, K. R., Perera, R., Roberts, N., & Glasziou, P. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-15 · Cited by 297
Sen, S., Mullan, M. M., Parker, T. J., Woolner, J. T., Tarry, S. A., & Hunter, J. O. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020597001460 · Cited by 245
Kamiya, T., Wang, L., Forsythe, P., Goettsche, G., Mao, Y., Wang, Y., Tougas, G., & Bienenstock, J. (2006) · Gut · doi:10.1136/gut.2005.070987 · Cited by 242
Ki Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.-D., Woong Lee, H., Joon Kim, H., Hyuk, J., Kyung Chang, S., Kim, K., Chung, W.-S., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31823712b1 · Cited by 216
NIV, E., NAFTALI, T., HALLAK, R., & VAISMAN, N. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.06.001 · Cited by 191
Schachtsiek, M., Hammes, W. P., & Hertel, C. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.12.7078-7085.2004 · Cited by 173 · cited 1×
“Their main beneficial effect is acting as a barrier to enteropathogens by adherence and competition with pathogens [37,38].”
BackgroundParkes, G. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01869.x · Cited by 167 · cited 1×
“This evidence highlights the potential of modifying gut microbial dysbiosis and bringing therapeutic benefits to IBS patients [5].”
BackgroundSinn, D. H., Song, J. H., Kim, H. J., Lee, J. H., Son, H. J., Chang, D. K., Kim, Y.-H., Kim, J. J., Rhee, J. C., & Rhee, P.-L. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0196-4 · Cited by 163 · cited 1×
“A number of studies have been conducted on the effect of probiotics on IBS patients, and some of them have reported favorable outcomes [12,30,31].”
BackgroundSelf-citationThe Current Prevalence of Irritable Bowel Syndrome in Asia
Chang, F., Lu, C., & Chen, T. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.4.389 · Cited by 133
O’Mahony, L., O’Callaghan, L., McCarthy, J., Shilling, D., Scully, P., Sibartie, S., Kavanagh, E., Kirwan, W. O., Redmond, H. P., Collins, J. K., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00112.2005 · Cited by 104 · cited 2×
“L. salivarius may influence immune regulation by increased induction of interleukin-10 (IL-10) [43], an anti-inflammatory cytokine, and reduced secretion of proinflammatory cytokines, such as tumor necrosis factor (TNF) alpha, IL-12, and interferon (IFN) gamma [44].”
BackgroundGut dysbiosis and irritable bowel syndrome: The potential role of probiotics
Principi, N., Cozzali, R., Farinelli, E., Brusaferro, A., & Esposito, S. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.12.013 · Cited by 103 · cited 1×
“intestinal sensitivity, and dysregulating the immune system activity [4].”
BackgroundLu, C., Chen, C.-M., Lang, H., Luo, J., Wang, S., Chang, F. ‐., & Lee, S. ‐. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01711.x · Cited by 94 · cited 1×
“This phenomenon may be due to cultural factors, degree of pain, socioeconomic conditions, and healthcare systems [19,20].”
BackgroundMüller-Lissner, S. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00027-1 · Cited by 91 · cited 3×
“They filled out the weekly questionnaires, which included a 5-point Likert scale of SGA [28] and VAS score [29].”
MethodAndriulli, A., Neri, M., Loguercio, C., Terreni, N., Merla, A., Cardarella, M. P., Federico, A., Chilovi, F., Milandri, G. L., De Bona, M., et al. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31817fadd6 · Cited by 75 · cited 2×
“paracase [26] have been conducted, and these organisms have shown effects on IBS symptoms.”
BackgroundGut Microbiota Diversity across Ethnicities in the United StatesPreprint
Brooks, A., Priya, S., Blekhman, R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/342915 · Cited by 62
Treating irritable bowel syndrome with probiotics: the evidence
Parkes, G. C., Sanderson, J. D., & Whelan, K. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s002966511000011x · Cited by 57 · cited 1×
“There is now increasing evidence linking alterations in the GI microbiota, dysbiosis, and IBS [3].”
BackgroundCeliberto, L. S., Pinto, R. A., Rossi, E. A., Vallance, B. A., & Cavallini, D. C. U. (2018) · Nutrients · doi:10.3390/nu10111684 · Cited by 47 · cited 1×
“In addition, gut microbiota differences between ethnicities have been studied and there is the potential to advance approaches aimed at personalized microbial treatment [14,15].”
BackgroundCho, Y.-H., Hong, S.-M., & Kim, C.-H. (2013) · Korean Journal for Food Science of Animal Resources · doi:10.5851/kosfa.2013.33.1.75 · Cited by 39 · cited 1×
“In addition, Lactobacillus paracasei has been isolated from Kimchi, a traditional Korean food [21,22].”
BackgroundA Survey of Irritable Bowel Syndrome in Vietnam Using the Rome Criteria
Zuckerman, M. J., Nguyen, G. T. H., Ho, H., Nguyen, L., & Gregory, G. G. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-9005-0 · Cited by 30 · cited 1×
“8%) of those with IBS symptoms reported having visited a physician in the past year for GI complaints [18].”
BackgroundDamodharan, K., Palaniyandi, S. A., Suh, J., & Yang, S. H. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09535-8 · Cited by 23 · cited 1×
“paracasei also showed high inhibition of pathogen adherence by competition and exclusion [42].”
BackgroundProbiotic Properties of Lactic Acid Bacteria isolated from Feces and Kimchi
Shin, H. S., Yoo, S. H., Jang, J. A., Won, J. Y., & Kim, C. H. (2017) · Journal of Dairy Science and Biotechnology · doi:10.22424/jmsb.2017.35.4.255 · Cited by 3
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Probiotics as Antibiotic Alternatives for Human and Animal Applications
Rabetafika, H. N., Razafindralambo, A., Ebenso, B., & Razafindralambo, H. L. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020040 · Cited by 116
“plantarum Effective global relief of IBS symptoms and abdominal pain without significant adverse events [135]”
BackgroundGut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 78
Varesi, A., Deumer, U.-S., Ananth, S. V., & Ricevuti, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215077 · Cited by 72
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 81
Metadata
- Authors
- Oh, J. H., Jang, Y. S., Kang, D., Chang, D. K., & Min, Y. W.
- Affiliations
- Samsung Medical Center (KR)
- Corresponding author
- Min, Yang Won
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-11-27
- Volume
- 11
- Issue
- 12
- Pages
- 2887
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6950464
- OpenAlex
- W2990905783
- Cited by
- 45
- References
- 46
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 8 · 2022: 16 · 2021: 6 · 2020: 5
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Agriculture, Food and Rural Affairs (MAFRA) (316061-3)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, lactobacilli, probiotics, abdominal symptoms, symptom relief, probiotic safety, Vietnamese patients
- MeSH terms
- Adult, Double-Blind Method, Female, Humans, Lactobacillus, Male, Placebos, Quality of Life, Vietnam, Abdominal Pain, Treatment Outcome, Probiotics, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.